Pharmacokinetic study of DSP-1958

Sumitomo Dainippon Pharma Co., Ltd.0 个研究点目标入组 15 人开始时间: 2016年11月9日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Collected adequate dose of hematopoietic stem cells.
•2) Ability to understand and the willingness to sign a written informed consent form.
•3) Negative pregnancy test.
•4) Taking appropriate contraceptive measures.
•5) ECOG PS of 0 to 2.
•6) Adequate liver function, renal function, and cardiac function.

•1) Receiving any treatment for primary disease.
•2) Received live attenuated vaccines within 90 days.
•3) Pregnant or breastfeeding.
•4) Uncontrolled intercurrent illness.
•5) Patients who are receiving any other investigational agents.
•6) Active infection.
•7) History of allergic reaction attributed to compounds of similar chemical composition.
•8) HBs Ag positive, HBs Ab positive, HBc Ab positive, HCV Ab positive, or HIV Ab positive.
•9) Difficult blood collection from vein.
•10) Planning or received within 14 days to treat hydropericardium, pleural effusion.
•11) Patients who had grapefruits or grapefruits juice, or St. John's wort within 13 days.
•12) Unsuitable for the clinical trial
•13) Unable to receive adequate rehydration and frequent blood transfusion.
•14) Received hematopoietic stem cell transplantation within 6 months.

发起方